Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental epirubicin poisoning |
Causative agent |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochloridprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 100 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 80 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 50 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 200mg/100mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 50 mg/25 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
epirubicin 2 mg/ml, opløsning til injektion, hætteglas a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 200 milligram/100 milliliter conventional release solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 200 milligram/100 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 10 milligram/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 10 milligram/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 50 milligram/25 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 50 milligram/25 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 2 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 2 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epirubicin hydrochloride |
Inferred relationship |
Some |
1 |